跳至主要内容
临床试验/NCT04662853
NCT04662853Unknown不适用

Gut Microbiota-based Tool for the Detection of Color-rectal Cancer in Positive Patients for the Fecal Occult Blood Test.

Maimónides Biomedical Research Institute of Córdoba1 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2017年1月17日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
153
试验地点
1
主要终点
Gut-microbiota-based color-rectal cancer diagnosis.

研究概览

简要总结

This clinical trial is focused in the development of a screening test for the people at risk of colo-rectal cancer (aged more than 50 years old), valid and safe, improving the screening prognosis increasing the sensitivity and sensitive as compared with the current method, fecal occult blood.

详细描述

Colo-rectal cancer (CCR) is one of the most prevalent cancers in developed countries. Several studies suggest that the CCR may be related with changes in the gut microbiota. This clinical trial is focused in the development of a screening test for the people at risk of CCR (aged more than 50 years old), valid and safe, improving the screening prognosis. The main potential improvement lies in the fact that the proposed method is more specific and sensitive than the current method, fecal occult blood. It aims to distinguish whether the positive results for fecal occult blood test is due to fissures, not related with CCR (which are positive for fecal occult blood, false positive) or was caused by a cancer-related lesion. The methodology derived will also improve the sensitive as sometimes the polyps do not leak blood. Based in the previous differences found in the gut microbiota composition related with CCR for several research groups, the gut microbiota composition will be used as diagnosis tool.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
50 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with positive results in the fecal occult blood test in the Program for Early Detection of Colon and Rectal Cancer, undergone by the Consejeria de Salud de la Junta de Andalucia (Spain).

排除标准

  • The consumption of antibiotic within the previous month to inclusion in the study.

结局指标

主要结局

Gut-microbiota-based color-rectal cancer diagnosis.

时间窗: A week before colonoscopy.

Determination of the gut microbiota composition by 16S metagenomic, data analysis and building of a mathematical model to test the potential use of the gut microbiota architecture as biomarker to color-rectal cancer prognosis in patients with positive results in fecal occult blood test.

次要结局

  • Colonoscopy clinical results.(At week 2.)
  • Dietary habits(A week before colonoscopy.)
  • Characteristic of the population.(A week before colonoscopy.)

研究者

发起方
Maimónides Biomedical Research Institute of Córdoba
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Gut Microbiota and Color-rectal Cancer. | 临床试验